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ABSTRACT 
In this work, fast dissolving films (FDF) were prepared using nanocrystal formulations in order to optimise dissolution properties of 
lipophilic, poorly soluble drug Cavedilol. Drug nanocrystals are crystals with a size in the nanometer range, meaning that they are 
nanoparticles with a crystalline character. Carvedilol nanosuspensions were prepared using a high-pressure homogenizer, and then 
encapsulated in to films by solvent casting method using polymers such as maltodextrin and PVA in different concentrations. 
Propylene glycol used as a plasticizer. This study aimed to develop and evaluate the formulation of FDF containing Carvedilol 
nanocrystals for enhanced bioavailability and better compliance. The formulation of FDF was optimized by Box-Behnken Design 
(BBD) (design expert 11.03).In this design, 13 formulas were performed. One of the formula were suggested by design expert 
desirability = 1. 
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INTRODUCTION  
Fast dissolving oral drug delivery system are solid dosage 
form which Fast-dissolving drug -delivery systems came 
into existence in the late 1970’s as an alternative to tablets, 
capsules and syrups for pediatric and geriatric patients 
who experience difficulties in swallowing traditional oral 
solid-dosage forms 1-5.  Fast-dissolving oral delivery 
systems are solid dosage forms, which disintegrate or 
dissolve within 1 min when placed in the mouth without 
drinking or chewing. They offer advantages such as 
administration without water, ease of swallowing, rapid 
onset of action and convenience of dosing. For fast 
dissolving active pharmaceutical ingredients, absorption is 
possible through the oral mucosa and may improve 
bioavailability1, 6-9. 
One of the major problems associated with poorly soluble 
drugs is very low bioavailability. 
The problem is even more complex for which are poorly 
soluble in both aqueous and non aqueous media, belonging 
to BCS class II as classified by biopharmaceutical 
classification system. Formulation as nanosuspension is an 
attractive and promising alternative to solve these 
problems. Preparation of nanosuspension is simple and 
applicable to all drugs which are water insoluble. 
Advantages of nanosuspension are 8-11;  
 Enhance the solubility and bioavailability of drugs.  
 Enhance the physical and chemical stability of drugs. 
 Higher drug loading can be achieved. 
 Dose reduction is possible. 
In this study, the nanosuspension was mixed with an 
aqueous solution containing fast dissolving film 
components and the final blend was casted by solvent 
casting method and dried, thus obtaining a nanocrystal-
loaded FDF. 
Carvedilol (CVD) is used for the treatment of essential 
hypertension, heart failure, and systolic dysfunction after 
myocardial infarction. Due to its lower aqueous solubility 
and extensive first-pass metabolism, the absolute 
bioavailability of CVD does not exceed 30%. Carvedilol is a 
nonselective beta adrenergic blocking agent with alpha-1 
blocking activity. In the present work solubility was 
enhanced by conversion of carvedilol to nanocrystals by 
high pressure homogenisation. Fast dissolving films were 
prepared by solvent casting method. Maltodextrin and PVA 
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were used as film forming polymers in different 
concentrations and propylene glycol is used as a 
plasticizer. Mannitol was used as a sweetening agent.  
Cross povidone is as a super disintegranting agent, citric 
acid as a saliva stimulating agent to avoid pre systemic 
metabolism3,  4, 10. 
MATERIALS AND METHODS 
Materials 
The drug Carvedilol was purchased from Yarrow Chem 
Products, Mumbai. Maltodextrin was obtained from Tokyo 
Chemical Industry Co., Ltd, Japan. Span 80 was obtained 
from Chemdyes Corporation, Rajkot, Gujarat. The other 
chemicals and reagents used were of analytical grade. 
Preparation of Carvedilol nanosuspension 3. 4. 12-15 
Preparation CVD nanosuspensions were prepared by high 
pressure homogenization. 5% (w/w) CVD coarse powder 
was dispersed in water with 1% (w/w) Tween 80 and 
disintegrated into micro suspensions by a high shear 
homogenizer at 8000 rpm for 30 min. Obtained micro 
suspensions were homogenized at high pressure using a 
homogenizer with a pressure guage. At first, 6 cycles at 500 
bar were conducted as pre-milling step, and then 30 cycles 
at 1000 bar were run to obtain the nanosuspension. The 
obtained nanosuspensions were Freeze dried or directly 
used to obtain fast dissolving films containing CVD 
nanocrystals. 
Preparation of different formulations of fast dissolving 
films 13-17 
Fast dissolving oral films were prepared by using a 
combination of polymers by solvent casting technique. The 
formulations were prepared as per table no.1. The 
hydrophilic polymers namely Maltodextrin (MD) and 
Polyvinylalchol (PVA) were accurately weighed and 
dissolved in distilled water and propylene glycol (PG) was 
added as a plasticizer. Nanosuspension and other 
ingredients were added to the polymeric dispersion under 
constant stirring with a magnetic stirrer and the resultant 
homogeneous solution was poured into a petridish. Then 
the films were dried in an oven at 50ºC for 24 h. The dried 
films were wrapped in a butter paper, covered with an 
aluminum foil and kept in a desiccator. 
Evaluation of Carvedilol nanosuspension 11-13 
To evaluate the effects of formulation processes on drug 
crystalline properties, the solid state of bulk CVD, freeze 
dried CVD nanocrystals, CVD nanocrystal-loaded film was 
investigated by XRD and shape and surface morphology 
analysed by SEM . 
Evaluation of Fast dissolving films 14-16 
Physical appearance; 
All the films were visually inspected for Colour, clarity, 
flexibility and smoothness. 
Morphology study 
The morphology of the films was studied using scanning 
electron microscope (SEM), at definite magnification. 
Thickness uniformity of the films 
The thickness of the film (2×2 cm2) was measured using 
screw gauge (thickness tester) at three different places; 
averages of three values and standard deviation were also 
calculated. 
 
Surface pH 
The surface pH of fast dissolving films was determined in 
order to investigate the possibility of any side effects in 
vivo. As an acidic or alkaline pH may cause irritation to the 
oral mucosa, it was determined to keep the surface pH as 
close to neutral as possible. The films were allowed to 
swell in closed petridish at room temperature for 30 
minutes in 5ml of distilled water. Solution was placed 
under digital pH meter. 
Folding endurance 
Folding endurance measures the ability of patch to 
withstand rupture, higher the folding endurance lower was 
chance of film to rupture easily and vice versa. It was 
determined by repeatedly folding a small strip of film of 
2×2 cm2at the same place until it broke. The number of 
times the film could be folded at the same place without 
breaking/cracking gave value of folding endurance. 
Drug content Uniformity of the film 
Drug content determination of the film was carried out by 
dissolving the film of 4 cm2 in 100 ml of pH 6.8 phosphate 
buffer using magnetic stirrer for 30 minutes. The drug 
concentration was then evaluated spectrophotometrically 
at 241nm. The determination was carried out in triplicate 
for all the formulations and average with standard 
deviation was recorded. 
Tensile strength 
Mechanical properties of polymeric fast dissolving film 
were conveniently determined by measuring their tensile 
strength. Tensile strength of films was determined using an 
apparatus fabricated in laboratory. A small film strip 
(1cm2) was cut and fixed to assembly. The weight required 
to break the film was noted and simultaneously film 
elongation was measured. 
Tensile strength =
              
            
 
 
  a, b, L = width, thickness and length of the strip. 
  ΔL = elongation at break. 
In-vitro disintegration time 
In vitro disintegration time was determined visually in a 
beaker containing 25 ml of pH 6.8 phosphate buffer with 
swirling every 10 sec. The disintegration time is the time 
when the film starts to break or disintegrates. 
In-vitro drug release 
The dissolution study was carried out using USP basket 
type XXIV dissolution apparatus. The dissolution was 
carried out in 900 ml of pH 6.8phosphate buffer 
maintained at 37 ± 0.50C at 50 rpm. The samples (5 ml) 
were taken at various time intervals and replaced with 
fresh buffer (pH 6.8) solution. The samples were filtered 
though whattman filter paper, diluted with buffer and 
analyzed by UV spectrophotometer at 241nm. 
Stability studies 
The stability studies were conducted by storing the 
formulated fast dissolving film at 40 ± 2ºC/75% RH in 
stability chamber for 45 days. The samples were 
withdrawn after 45 days and analyzed for physical 
appearance, drug content and in-vitro drug release. 
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Optimization by BOX-BEHNKEN factorial design 5, 15 
In this optimization design, three factors were evaluated, 
each at two levels. The independent factors were amount 
of Maltodextrin (X1) and polyvinyl alchol (X2) propylene 
glycol (X3) and the response variables were percentage 
drug release (Y1), Tensile strength (Y2). Thirteen 
formulations were prepared according to the Factorial 
design. The responses obtained from the design matrix 
were statistically evaluated using statistical software trial 
package design expert 11.03 
RESULTS AND DISCUSSION 
XRD Analysis 
 
 
Figure 1: Diffraction pattern of bulk CVD 
 
 
Figure 2: Diffraction pattern of CVD nanocrystal 
 
Figure 3: Diffraction pattern of CVD nanocrystal loaded Fast dissolving film 
Sharma et al                                                                                                             Journal of Drug Delivery & Therapeutics. 2018; 8(6):74-81 
ISSN: 2250-1177                                                                                    [77]                                                                                 CODEN (USA): JDDTAO 
From this study,The freeze-dried nanocrystal 
diffractograms showed some diffraction peaks attributed 
to crystalline CVD although a few peaks were shifted. The 
differences in peak relative intensities and the partial 
amorphisation are probably due to the high pressure 
homogenization process. Indeed, as pre-viously 
demonstrated, during homogenization, cavitation forces as 
well as collision and shear forces determine break down of 
the drug particles down to the nanometer range. The XRD 
pattern of pure drug Carvedilol shows peaks which are 
intense and sharp shows the crystalline nature of the drug. 
The XRD pattern of CVD nanocrystal loaded fast dissolving 
film showed undefined, broad peaks with less intensity  
The peak of diminished intensity shows the decrease in 
Crystallinity of the drug and the nature of the drug 
converted to amorphous form and thus improved solubility 
of the drug.  
Shape and surface morphology 
SEM Analysis: 
The surface morphology was observed by Scanning 
Electron Microscopy and was found to be as in the 
figure4,5,6. Nanocrystal (figure 5) s Film disclosed (Figure 
6) a rough surface and showed, mixed with film matrix, 
several CVD nanocrystals arranged in different positions 
and orientations. 
 
Figure4: SEM Analysis of bulk CVD 
 
Figure5: SEM Analysis of CVD nanocrystals 
 
 
Figure6: SEM Analysis of CVD nanosuspension loaded 
fast dissolving film
 
 
Optimisation of fast dissolving film 
Table 1: formulation table for the fast dissolving film as per the factorial (adjusted) design 
Formulation 
code 
Maltodextrin 
(mg) 
PVA 
(mg) 
PEG 
(ml) 
Cross 
povidonne 
(mg) 
Citric acid 
(mg) 
Mannitol 
(mg) 
D.W 
F1 300 200 1 20 20 20 q.s 
F2 300 200 2 20 20 20 q.s 
F3 100 500 2 20 20 20 q.s 
F4 300 500 2 20 20 20 q.s 
F5 100 350 1 20 20 20 q.s 
F6 300 350 1 20 20 20 q.s 
F7 100 350 3 20 20 20 q.s 
F8 300 350 3 20 20 20 q.s 
F9 200 200 1 20 20 20 q.s 
F10 200 500 1 20 20 20 q.s 
F11 200 200 3 20 20 20 q.s 
F12 200 500 3 20 20 20 q.s 
F13 100 200 2 20 20 20 q.s 
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In vitro drug release study 
The in vitro drug release profiles of the formulations in pH 
6.8 phosphate buffer show differences depending on their 
composition as given in following tables. A rapid 
dissolution of all the film preparations was observed by the 
dissolution test, in which above 90% of CVD was released 
within 5 min. The formulation F8 shows maximum drug 
release (98.01) within 5 minutes 
 
Comparison of the in-vitro drug diffusion profile of formulations F1-F13  
               
 
           
 
Table 2: the factors and responses for 13 formulations 
   
FORMULATION 
CODE  
FACTORS RESPONSES  
X1 
Maltodextrin(mg) 
X2-Polyvinyl 
Alcohol (mg) 
X3-Propylene 
glycol(ml) 
Y1-Invitro 
release(%) 
Y2- Tensile strength 
(mg/cm
2
) 
F1  300  200  1  95.12  14253.2  
F2  300  200  2  95.61  9661.8  
F3  100  500  2  97.49  16483.5  
F4  300  500  2  96.43  12558.8  
F5  100  350  1  97.68  13300  
F6  300  350  1  95.22  11111.1  
F7  100  350  3  96.12  14128.7  
F8  300  350  3  98.01  11235.9  
F9  200  200  1  95.75  13227.5  
F10  200  500  1  97.01  14814.8  
F11  200  200  3  95.81  11441.6  
F12  200  500  3  97.91  13550.1  
F13  100  200  2  94.96  12374.5  
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Tensile strength  
Mechanical properties of polymeric fast dissolving film 
were conveniently determined by measuring their tensile 
strength.The film film showing a good Tensile strength. The 
formulation F8 shows maximum Tensile strength 11235.9 
mg/cm2 
. 
 
 
Contour plot and Response surface plot for the effect of Maltodextrin and PVA and PG on Drug release  
       
 
Contour plot and Response surface plot for the effect of Maltodextrin , PVA and PG on Tensile strength 
            
 
Development of the optimum batch 
Based on the statistical evaluations the software suggested a good number of combinations of which we selected one as 
optimum batch. 
Maltodextrin(mg)  Propylene 
Glycol(ml)  
Polyvinyl 
alcohol(mg)  
Tensile 
strength(mg/cm)  
In-vitro release 
(%)  
Desirability  
300  3  350  11235.9  98.01  1.0  
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Evaluation of optimized formulation of Fast dissolving 
film 
Appearance of films: 
Appearances of films were evaluated by visual observation 
such as transparent or opaque. The fabricated films were 
thin, flexible, elastic, smooth and transparent.  
 
Figure 7: Formuliation 8 
Thickness of film: 
 Results showed that thickness of all formulations was 
varied from 0.19 to 0.26. Low deviation value in film 
thickness measurements ensured uniformity of patches 
prepared by solvent evaporation technique.  
Surface pH: 
The surface pH of the films was ranging from 6.72 -7.35. 
Since the surface pH of the films was found to be around 
the neutral pH, there will not be any kind of irritation to 
the oral mucosa.  
Folding endurance: 
In order to evaluate the flexibility, the films were subjected 
to folding endurance studies. The values were above 250 
in all batches. This revealed that the prepared films were 
having capacity to withstand the mechanical pressure 
along with good flexibility. 
Drug content uniformity: 
The percentage drug content in optimised formulation 
found to be 98.78 ±0.64 %. The drug content was found to 
be in acceptable range indicating uniform distribution of 
drug. 
In vitro disintegration time: 
In-vitro disintegration time studies as shown that films 
prepared had in-vitro disintegration time below 30 sec and 
was thus, acceptable in range.  
Stability Study 
From the results it was found that formulation F8 was the 
best formulation amongst the nine formulations. Thus 
formulation F1 was selected for stability studies. No major 
differences were found between evaluated parameters 
before and after storage and all were in acceptable limits. 
The formulations showed satisfactory physical stability at 
40°C at 75 % RH 
CONCLUSION 
Carvedilol nanocrystal loaded fast dissolving films were 
successfully developed and evaluated. Nanocrystals of drug 
were prepared by thigh pressure homogenisation method 
using Tween 80 and water. It was evaluated for the XRD 
and SEM analysis.  Fast dissolving films were prepared by 
using solvent casting method. Optimization of the prepared 
fast dissolving film was done by Box bhenken method 
using design expert 11.03.The optimized Films were found 
to be satisfactory when evaluated for thickness,  in-vitro 
drug release, folding endurance, drug content, 
disintegration time and Tensile strength .The surface pH of 
all the films was found to be neutral. The in-vitro drug 
release in optimized formulation F8was found to be 
98.01% in 5 min and Tensile strength was found to be 
11235.9mg/cm2. The optimized formulation F8 also 
showed satisfactory pH, drug content (98.78 ±0.64 %), 
effective), disintegration time of 23 seconds and 
satisfactory stability. Fast dissolving film can be a potential 
novel drug dosage form for pediatric, geriatric and also for 
general population. 
FUTURE ASPECT 
  Films with different compositions need to be studied. 
 By altering the methodology, we could further reduce 
the particle size, thereby improve the kinetic profile.  
 Further studies including animal experiments need to 
be studied for analyzing the efficacy of the 
formulation. 
 Further studies for the determination of an 
appropriate dose based on clinical trials. 
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